Janice Pogue
Cited by
Cited by
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
Dabigatran versus warfarin in patients with atrial fibrillation
SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ...
New England Journal of Medicine 361 (12), 1139-1151, 2009
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
New England Journal of Medicine 345 (7), 494-502, 2001
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
S Yusuf, P Sleight, J Pogue, J Bosch, R Davies, G Dagenais
The New England journal of medicine 342 (3), 145-153, 2000
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events …
HG Site
Lancet 367 (9526), 1903-1912, 2006
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial
POISE Study Group
The Lancet 371 (9627), 1839-1847, 2008
Homocysteine lowering with folic acid and B vitamins in vascular disease
Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
New England Journal of Medicine 354 (15), 1567-1577, 2006
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients
MD Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, ...
The Lancet 355 (9215), 1575-1581, 2000
Vitamin E supplementation and cardiovascular events in high-risk patients.
S Yusuf, G Dagenais, J Pogue, J Bosch, P Sleight
The New England journal of medicine 342 (3), 154-160, 2000
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
JFE Mann, RE Schmieder, M McQueen, L Dyal, H Schumacher, J Pogue, ...
The Lancet 372 (9638), 547-553, 2008
Basal insulin and cardiovascular and other outcomes in dysglycemia
ORIGIN Trial Investigators
New England Journal of Medicine 367 (4), 319-328, 2012
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial
JFE Mann, HC Gerstein, J Pogue, J Bosch, S Yusuf, Hope Investigators
Annals of internal medicine 134 (8), 629-636, 2001
Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies
L De Koning, AT Merchant, J Pogue, SS Anand
European heart journal 28 (7), 850-856, 2007
Comparison of fondaparinux and enoxaparin in acute coronary syndromes
Fifth Organization to Assess Strategies in Acute Ischemic Syndromes ...
New England Journal of Medicine 354 (14), 1464-1476, 2006
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
E Lonn, J Bosch, S Yusuf, P Sheridan, J Pogue, JM Arnold, C Ross, ...
Jama 293 (11), 1338-1347, 2005
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis …
L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ...
The Lancet 376 (9745), 975-983, 2010
Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot …
RS McKelvie, S Yusuf, D Pericak, A Avezum, RJ Burns, J Probstfield, ...
Circulation 100 (10), 1056-1064, 1999
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised …
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ...
The Lancet 372 (9644), 1174-1183, 2008
The system can't perform the operation now. Try again later.
Articles 1–20